TRIAL WATCH Phase III promise for oral multiple sclerosis therapy

被引：0
|
作者：
不详
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 02期
关键词：
D O I：
10.1038/nrd2821
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [41] TRIAL WATCH Phase III success for novel Clostridium difficile antibiotic
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (04) : 260 - 260
  • [42] TRIAL WATCH Phase III and submission failures: 2007-2010
    Arrowsmith, John
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (02) : 1 - 1
  • [43] TRIAL WATCH Enzyme replacement success in Phase III trial for rare metabolic disorder
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (01) : 12 - 12
  • [44] Multiple Sclerosis: Prospects and Promise
    Hauser, Stephen L.
    Chan, Jonah R.
    Oksenberg, Jorge R.
    ANNALS OF NEUROLOGY, 2013, 74 (03) : 317 - 327
  • [45] Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
    O'Connor, Paul
    Wolinsky, Jerry S.
    Confavreux, Christian
    Comi, Giancarlo
    Kappos, Ludwig
    Olsson, Tomas P.
    Benzerdjeb, Hadj
    Truffinet, Philippe
    Wang, Lin
    Miller, Aaron
    Freedman, Mark S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1293 - 1303
  • [46] Remyelination therapy goes to trial for multiple sclerosis
    Brugarolas, Pedro
    Popko, Brian
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2014, 1 (02):
  • [47] Phase III clinical trial using daclizumab for relapsing-remitting multiple sclerosis initiated
    不详
    IMMUNOTHERAPY, 2010, 2 (04) : 437 - 437
  • [48] Baseline Immunological Profile in Secondary Progressive Multiple Sclerosis Patients of Phase III EXPAND Trial
    Mao-Draayer, Yang
    Wu, Qi
    Wang, Qin
    Lundy, Steve K.
    Dowling, Catherine
    Segal, Benjamin Matthew M.
    Fox, David
    Wallstroem, Erik
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 12 - 12
  • [49] Phase II trial of evobrutinib in multiple sclerosis
    Kelsey R.
    Nature Reviews Neurology, 2019, 15 (8) : 434 - 434
  • [50] Baseline Immunological Profile in Secondary Progressive Multiple Sclerosis Patients of Phase III EXPAND Trial
    Mao-Draayers, Yang
    Wu, Qi
    Wang, Qin
    Dowling, Catherine
    Lundy, Steven
    Segal, Benjamin
    Wallstrom, Wallstrom
    NEUROLOGY, 2016, 86
12345